These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8379534)

  • 1. Adenocarcinoma of the prostate. Part II: Tissue prognosticators.
    Humphrey PA; Walther PJ
    Am J Clin Pathol; 1993 Sep; 100(3):256-69. PubMed ID: 8379534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on prostate pathology.
    Osunkoya AO
    Pathology; 2012 Aug; 44(5):391-406. PubMed ID: 22772344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
    Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
    Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minute focus of prostate cancer on needle biopsy: correlation with radical prostatectomy specimen.
    Montanari E; Del Nero A; Gazzano G; Mangiarotti B; Bernardini P; Longo F; Cordima G; Itri E
    Arch Ital Urol Androl; 2009 Mar; 81(1):9-12. PubMed ID: 19499751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK; Daggy JK; Cheng L
    Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR; Bostwick DG; Myers RP; Oesterling JE
    J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concordance between Gleason scores of trans rectal biopsies and the surgical piece of radical prostatectomy].
    Tapia O; Bellolio E; Roa JC; Guzmán P; Villaseca M; Araya JC
    Rev Med Chil; 2011 Feb; 139(2):171-6. PubMed ID: 21773653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of expectant therapy in prostatic carcinoma of low grade and staging].
    Lorusso A; Curatolo C; Giocoli Nacci G; Ludovico GM; Cirillo Limitone DA; Marucco EC; Pagliarulo A
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):155-7. PubMed ID: 9162350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, staging, and surgical treatment of prostatic carcinoma.
    Catalona WJ; Avioli LV
    Arch Intern Med; 1987 Feb; 147(2):361-3. PubMed ID: 3813756
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimal focus of adenocarcinoma on prostate biopsy: clinicopathological correlations.
    Leroy X; Aubert S; Villers A; Ballereau C; Augusto D; Gosselin B
    J Clin Pathol; 2003 Mar; 56(3):230-2. PubMed ID: 12610105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic role of perineural invasion in prostate biopsy].
    Gutiérrez C; Terrasa F; Briones G; Conde G; Fuentes I; Hidalgo F; Bestard J; Rebassa M
    Actas Urol Esp; 2011 Jun; 35(6):347-53. PubMed ID: 21435742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can prostate biopsies predict suitability for nerve-sparing radical prostatectomy?
    Connolly SS; O'Malley KJ; O'Brien A; Kelly DG; Mulvin DW; Quinlan DM
    Scand J Urol Nephrol; 2004; 38(3):216-20. PubMed ID: 15204374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
    Karram S; Trock BJ; Netto GJ; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasion of fat justifies assignment of stage pT3a in prostatic adenocarcinoma.
    Sung MT; Eble JN; Cheng L
    Pathology; 2006 Aug; 38(4):309-11. PubMed ID: 16916718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI
    J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic evaluation of prostatic carcinoma: critical information for the oncologist.
    Epstein JI
    Oncology (Williston Park); 1996 Apr; 10(4):527-34; discussion 539, 541-3. PubMed ID: 8723283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on Grading and Staging of Prostate Cancer.
    Braunhut BL; Punnen S; Kryvenko ON
    Surg Pathol Clin; 2018 Dec; 11(4):759-774. PubMed ID: 30447840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
    Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.